Level39

Fin|Tech|Bio returned for its third edition, bringing together leaders across finance, technology, and life sciences to explore where these sectors are converging.

From a preview of CPRD Emulate by Clinical Practice Research Datalink to insights from Our Future Health, Applied Blockchain and IMU Biosciences, the conversation explored the opportunities shaping the UK’s future.

Topics ranged from unlocking multimodal health data and advancing precision medicine to scaling AI responsibly and building trust infrastructure across industries.

With innovation accelerating across Canary Wharf and major developments like One North Quay on the horizon, the momentum between fintech and life sciences is only growing.

Thank you to our partners at Life Sciences and everyone who joined us to drive these conversations forward at Level39.

What do you get when you mix finance, tech, and biotech?

A packed room and an evening of incredible insights!

Last week’s Fin|Tech|Bio at Canary Wharf was a sold-out success, sparking thought-provoking conversations and new connections. Our expert panel explored the opportunities at the intersection of these industries, alongside insights into Level39’s growing Life Sciences community and the game-changing North Quay development.

Huge thanks to our speakers and attendees for an engaging evening. Stay tuned for the next one! 🚀